Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definition
1.3 Base estimates & calculations
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data Sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Absorbable nasal implant devices industry 360º synopsis, 2018 – 2032
2.2 Business trends
2.3 Regional trends
2.4 Product type trends
2.5 Material type trends
2.6 End-use trends
Chapter 3 Absorbable Nasal Implant Devices Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of nasal congestion
3.2.1.2 Rising number of nasal reconstruction surgeries, such as rhinoplasty and septoplasty
3.2.1.3 Technological advancements
3.2.1.4 Rising demand & surged awareness
3.2.2 Industry pitfalls & challenges
3.2.2.1 Lack of product awareness
3.3 Growth potential analysis
3.3.1 By product type
3.3.2 By material type
3.3.3 By end use
3.4 COVID- 19 impact analysis
3.5 Pricing analysis, 2022, by region
3.5.1 North America
3.5.1.1 U.S.
3.5.1.2 Canada
3.5.2 Europe
3.5.2.1 Germany
3.5.2.2 UK
3.5.2.3 France
3.5.2.4 Spain
3.5.2.5 Italy
3.5.2.6 Poland
3.5.2.7 Switzerland
3.5.2.8 The Netherlands
3.5.3 Asia Pacific
3.5.3.1 China
3.5.3.2 Japan
3.5.3.3 India
3.5.3.4 Australia
3.5.3.5 South Korea
3.5.3.6 Indonesia
3.5.3.7 Philippines
3.5.3.8 Vietnam
3.5.4 Latin America
3.5.4.1 Brazil
3.5.4.2 Mexico
3.5.4.3 Argentina
3.5.4.4 Colombia
3.5.4.5 Chile
3.5.4.6 Peru
3.5.5 MEA
3.5.5.1 South Africa
3.5.5.2 Saudi Arabia
3.5.5.3 UAE
3.5.5.4 Israel
3.5.5.5 Egypt
3.5.5.6 Turkey
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.7 Reimbursement scenario
3.8 Product launch/approval scenario
3.9 Material type insights
3.10 Key market trends
3.11 Technological advancements
3.12 Gap Analysis
3.13 Porter's analysis
3.14 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Global company market share analysis, 2022
4.4 Vendor matrix analysis
4.5 Competitive positioning matrix
4.6 Strategy dashboard, 2022
Chapter 5 Size and Forecast, By Product Type (USD Million & Units)
5.1 Key trends, by product type
5.2 Drug Eluting Absorbable Nasal Implant Devices
5.2.1 Corticosteroids Eluting Implants
5.2.2 Antibiotics Eluting Implants
5.2.3 Others
5.3 Non-Drug Eluting Nasal Implants Devices
Chapter 6 Size and Forecast, By Material Type (USD Million)
6.1 Key trends, by material type
6.2 Polymer
6.3 Carboxy Methyl Cellulose (CMC)
6.4 Others
Chapter 7 Size and Forecast, By End-use (USD Million)
7.1 Key trends, by end-use
7.2 Hospitals
7.3 Ambulatory Surgical Centers
7.4 Others
Chapter 8 Size and Forecast, By Region (USD Million & Units)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Poland
8.3.7 Switzerland
8.3.8 The Netherlands
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Indonesia
8.4.7 Philippines
8.4.8 Vietnam
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Colombia
8.5.5 Chile
8.5.6 Peru
8.6 MEA
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Israel
8.6.5 Egypt
8.6.6 Turkey
Chapter 9 Company Profiles
9.1 Smith and Nephew plc
9.2 Intersect ENT, Inc.
9.3 Spirox, Inc. (Entellus Medical)
9.4 Stryker Corporation
9.5 Johnson & Johnson, Inc.
9.6 SinuSys Corporation
9.7 Surgiform Technology Ltd
